Biomerica (BMRA) announced that the American Medical Association CPT editorial panel has issued a Current Procedural Terminology, CPT, code in the Proprietary Laboratory Analysis, PLA, code category for the Company’s inFoods IBS test. This newly granted PLA code assigns a unique identifier to the test, allowing for the submission of claims to Medicare and private insurers for the Company’s inFoods IBS test once the code becomes effective on October 1, 2025. The PLA code represents a next step on the pathway to expand patient access to the inFoods IBS test.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRA:
- Biomerica announces appointment of Madel as Chief Commercial Officer
- Biomerica Appoints Eric B. Chin to Board
- Biomerica announces publication of data from inFoods IBS clinical study
- Biomerica announces real-world results of its inFoods IBS product
- Biomerica submits application for PLA code for inFoods IBS diagnostic test